Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD6738 potentiates cisplatin efficacy in NSCLC xenografts, and the ...
(PDF) Phase II study of ceralasertib (AZD6738) in combination with ...
The orally active and bioavailable ATR kinase inhibitor AZD6738 ...
Phase II study of ceralasertib (AZD6738) in combination with durvalumab ...
AZD6738 in combination with FTD decreases Chk1 phosphorylation. HT29 ...
AZD6738 abrogates the olaparib-induced DNA damage G2-M checkpoint a ...
Radiosensitization by the ATR Inhibitor AZD6738 through Generation of ...
AZD6738 – 美仑生物
AZD6738 monotherapy induces cell cycle arrest in sensitive cell lines ...
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a ...
JCI - ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent ...
Single-Cell Transcriptional Analysis Reveals the Mechanism of AZD6738 ...
AZD6738 induces DNA damage, apoptosis, and exhibits anti-tumor efficacy ...
AZD6738 reduced TGF-β1-induced cell proliferation and migration in ...
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In ...
AZD6738 sensitizes ATM knockdown cells to cisplatin. A. Western blot ...
AZD6738 enhances 5-FU-induced apoptosis in HT29 cells. (A) HT29 cells ...
Combination therapy with TAS-102 and AZD6738 effectively inhibits tumor ...
Anti‐tumor activity of the ATR inhibitor AZD6738 in HER2 positive ...
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent ...
CDC7 inhibitor synergies with AZD6738 or MK-8776 in HCC cells. a, b ...
Frontiers | AZD6738 Inhibits fibrotic response of conjunctival ...
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair ...
The cell survival curves of irradiation in combination with AZD6738 ...
(A) Clonogenic survival assay for AZD6738 in 231control and XRCC1_KO ...
AZD6738 (Ceralasertib) | ATR inhibitor | Probechem Biochemicals
AZD6738 promotes radioimmunotherapy antitumor effect via activating ...
AZD6738 inhibits maintenance of G 2 checkpoints. (A) HT29 cells were ...
The combination of AZD6738 and cisplatin causes dramatic cell death of ...
Relationship between sensitivity to MK-8776 or AZD6738 and endogenous ...
Mitotic catastrophe caused by AZD6738 in combination with belotecan may ...
(a) Representative dose response curve for AZD6738 in a panel of ...
The synergistic effect was observed with combinations of AZD6738 and ...
Effects of AZD6738 monotherapy or combined with CDC7 inhibitor in vivo ...
ATR inhibition by AZD6738 exacerbates AZD1775-induced RS and abrogates ...
Combined olaparib and AZD6738 treatment results in earlier commitment ...
ATR inhibitor AZD6738 potentiates anti-proliferation of WEE1 inhibitor ...
The viability of A375 cells following AZD6738 and radiation treatment ...
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy ...
PK and NCA of AZD6738 from bioavailability and dose linearity studies ...
Metronomic dosing of ovarian cancer cells with the ATR inhibitor ...
Synergism of AZD6738, an ATR Inhibitor, in Combination with Belotecan ...
Hypoxia‐Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively ...
Oncology Reports
Scheme 3. Synthesis of AZD6738. | Download Scientific Diagram
Ceralasertib (AZD6738) | ATR Inhibitor | CAS 1352226-88-0 | Selleck ...
AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality ...
(PDF) Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in ...
AZD6738, an ATR inhibitor, in combination with belotecan demonstrates ...
Sensitivity of cell lines to MK-8776 and AZD6738. (A) Each cell line ...
Contribution of cell cycle phases, during which ATR and/or Wee1 was ...
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination ...
Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural ...
Ceralasertib (AZD6738) | CAS 1352226-88-0 | AbMole BioScience ...
Synthesis method of pyrimidine heterocyclic ring-containing antitumor ...
Knockdown of RNF126 leads to decreased replication stress. A, C Western ...
Combined olaparib/AZD6738 treatment causes cell death in ATM-mutant ...
Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia ...
